Analysis Metabolite Name Measured Value Units Gender Glycemic status Neuropathy
Reversed phase NEGATIVE ION MODECORTISONE (M+CL)-7160Peak area normalizedfemale diabetic Neuropathy
Reversed phase NEGATIVE ION MODECORTISONE (M+CL)-10185Peak area normalizedfemale diabetic Neuropathy
Reversed phase NEGATIVE ION MODECORTISONE (M+CL)-10980Peak area normalizedfemale normoglycemic Neuropathy
Reversed phase NEGATIVE ION MODECORTISONE (M+CL)-11624Peak area normalizedfemale diabetic no neuropathy
Reversed phase NEGATIVE ION MODECORTISONE (M+CL)-12566Peak area normalizedfemale diabetic no neuropathy
Reversed phase NEGATIVE ION MODECORTISONE (M+CL)-15343Peak area normalizedfemale normoglycemic no neuropathy
Reversed phase NEGATIVE ION MODECORTISONE (M+CL)-15891Peak area normalizedmale diabetic Neuropathy
Reversed phase NEGATIVE ION MODECORTISONE (M+CL)-16768Peak area normalizedmale pre-diabetic Neuropathy
Reversed phase NEGATIVE ION MODECORTISONE (M+CL)-18073Peak area normalizedfemale diabetic Neuropathy
Reversed phase NEGATIVE ION MODECORTISONE (M+CL)-20064Peak area normalizedfemale diabetic Neuropathy
Reversed phase NEGATIVE ION MODECORTISONE (M+CL)-24424Peak area normalizedmale pre-diabetic no neuropathy
Reversed phase NEGATIVE ION MODECORTISONE (M+CL)-27036Peak area normalizedfemale diabetic no neuropathy
Reversed phase NEGATIVE ION MODECORTISONE (M+CL)-35050Peak area normalizedmale diabetic no neuropathy
Reversed phase NEGATIVE ION MODECORTISONE (M+CL)-Peak area normalizedfemale diabetic no neuropathy

Return to search page
  logo